Baolingbao Biology (002286.SZ) has obtained the production license for lactulose active pharmaceutical ingredients.

15:46 31/10/2025

BoLinbao (002286.SZ) issued an announcement. Recently, the company has obtained the "..." issued by the Shandong Provincial Drug Administration.

Baolingbao Biology (002286.SZ) announced that the company recently obtained the "Drug Production License" issued by the Shandong Provincial Drug Administration. The production address and scope are: No. 1 Dongwaihuan Road, High-tech Industrial Development Zone, Yucheng, Dezhou, Shandong; API (lactulose concentrated solution) (limited to registered use). Obtaining the "Drug Production License" has accelerated the company's first API lactulose's follow-up declaration, registration, and listing process, marking the beginning of the company's diversified layout of APIs.

Inventronics (300582.SZ) plans to launch an employee stock ownership plan for 2025.

Greentech Intl (00195) appoints United Vision Enterprise Consulting as internal control consultant.

POLYFAIR Holdings (08532) has released its annual performance, with a net loss of HK$133 million, a turnaround from a profit in the previous year.

Inventronics (300582.SZ) plans to launch an employee stock ownership plan for 2025.

Greentech Intl (00195) appoints United Vision Enterprise Consulting as internal control consultant.

POLYFAIR Holdings (08532) has released its annual performance, with a net loss of HK$133 million, a turnaround from a profit in the previous year.